Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Nov 12, 2019 (7 years ago)

Budesonide 0.4mg

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Processing Controls

Cause type: cGMP deviation

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards. All cgmp deviation recalls.

What was recalled

Budesonide 0.4mg, 3ML Vial, For Inhalation Only, Conversio Health, San Luis Obispo, CA 93401.

Drug: Budesonide

Recalling firm
Integrated Health Concepts Inc. dba Conversio Health
Origin
CA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0508-2020 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Budesonide recalls

See all
Class II · Moderate risk

Budesonide Inhalation Suspension

Presence of Foreign Substance:This recall has been initiated in response to a product quality complaint reported for black/brown specs and particles within the ampoule solution

Ongoing Particulate / foreign matter Sun Pharmaceutical Industries INC NDC 47335-633-49 D-0607-2026

Other recalls by Integrated Health Concepts Inc. dba Conversio Health

All 2019 recalls